CIPROGUD

This brand name is authorized in Nigeria.

Active ingredients

The drug CIPROGUD contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7390	Tablet	CIPROGUD TABLETS TAB 500 mg 1X10	53 RNW-PP-274695 CIPROGUD TABLETS CIPROFLOXACIN HYDROCHLORIDE USP 500MG Ciprofloxacin Hydrochloride USP tablets 500mg. Exceipients: Q.S B4-7390 Drugs Imported Products 1x10 POM 1 8/5/2022 IBU PHARM NIG. LTD, CHURCH STREET,LAGOS LAGOS LAGOS 8184435083 ibupharm240@gmail.com IMPULSE PHARMA PVT LTD., PLOT NO . J - 201/202, MIDC, TARAPUR, TAL.PALGHAR, BOISAR, DIST. THANE, THANE 401501 INDIA., India	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7390